<SEC-DOCUMENT>0000950103-21-002397-index.html : 20210217 <SEC-HEADER>0000950103-21-002397.hdr.sgml : 20210217 <ACCEPTANCE-DATETIME>20210217160339 ACCESSION NUMBER: 0000950103-21-002397 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20210217 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1226 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 21644686 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC DATE OF NAME CHANGE: 20000605 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>dp146258_8k.htm <DESCRIPTION>FORM 8-K <TEXT> Document 1 - file: dp146258_8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-2.1 <SEQUENCE>2 <FILENAME>dp146258_ex0201.htm <DESCRIPTION>EXHIBIT 2.1 <TEXT> Document 2 - file: dp146258_ex0201.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>3 <FILENAME>dp146258_ex1001.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 3 - file: dp146258_ex1001.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>dp146258_ex9901.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 4 - file: dp146258_ex9901.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.LAB <SEQUENCE>6 <FILENAME>crl-20210217_lab.xml <DESCRIPTION>XBRL LABEL FILE <TEXT> Document 6 - file: crl-20210217_lab.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.PRE <SEQUENCE>7 <FILENAME>crl-20210217_pre.xml <DESCRIPTION>XBRL PRESENTATION FILE <TEXT> Document 7 - file: crl-20210217_pre.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-101.SCH <SEQUENCE>8 <FILENAME>crl-20210217.xsd <DESCRIPTION>XBRL SCHEMA FILE <TEXT> Document 8 - file: crl-20210217.xsd
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>9 <FILENAME>dp146258_8k_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 9 - file: dp146258_8k_htm.html
Document 9 - RAW XML: dp146258_8k_htm.xml
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>10 <FILENAME>R1.htm <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 10 - file: R1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EXCEL <SEQUENCE>11 <FILENAME>Financial_Report.xlsx <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 11 - file: Financial_Report.xlsx
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>12 <FILENAME>Show.js <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 12 - file: Show.js
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>13 <FILENAME>report.css <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 13 - file: report.css
</DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>14 <FILENAME>FilingSummary.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 14 - file: FilingSummary.html
Document 14 - RAW XML: FilingSummary.xml
</DOCUMENT> <DOCUMENT> <TYPE>JSON <SEQUENCE>16 <FILENAME>MetaLinks.json <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 16 - file: MetaLinks.json
</DOCUMENT> <DOCUMENT> <TYPE>ZIP <SEQUENCE>17 <FILENAME>0000950103-21-002397-xbrl.zip <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> Document 17 - file: 0000950103-21-002397-xbrl.zip
</DOCUMENT> </SEC-DOCUMENT>